Evidence map›Paper›PMID 35883376›Full record

ArticleAnimals : an open access journal from MDPI2022

One-Step In Vitro Generation of ETV2-Null Pig Embryos.

Marta Moya-Jódar, Giulia Coppiello, Juan Roberto Rodríguez-Madoz, Gloria Abizanda, Paula Barlabé, Amaia Vilas-Zornoza, Asier Ullate-Agote, Chiara Luongo, Ernesto Rodríguez-Tobón, Sergio Navarro-Serna and 7 more

Open access · goldAbstract read
In one paragraph

Article in Animals : an open access journal from MDPI, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Marta Moya-JódarProgram of Regenerative Medicine, Centre for Applied Medical Research (CIMA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), University of Navarra, 31008 Pamplona, Spain.ORCID 0000-0003-4141-3509
Giulia CoppielloProgram of Regenerative Medicine, Centre for Applied Medical Research (CIMA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), University of Navarra, 31008 Pamplona, Spain.ORCID 0000-0001-6896-1084
Juan Roberto Rodríguez-MadozProgram of Regenerative Medicine, Centre for Applied Medical Research (CIMA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), University of Navarra, 31008 Pamplona, Spain.ORCID 0000-0003-4327-1866
Gloria AbizandaProgram of Regenerative Medicine, Centre for Applied Medical Research (CIMA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), University of Navarra, 31008 Pamplona, Spain.
Paula BarlabéProgram of Regenerative Medicine, Centre for Applied Medical Research (CIMA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), University of Navarra, 31008 Pamplona, Spain.ORCID 0000-0002-1559-6498
Amaia Vilas-ZornozaAdvanced Genomics Laboratory, Program of Hemato-Oncology, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain.
Asier Ullate-AgoteProgram of Regenerative Medicine, Centre for Applied Medical Research (CIMA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), University of Navarra, 31008 Pamplona, Spain.ORCID 0000-0002-8595-7703
Chiara LuongoDepartment of Physiology, Veterinary School, International Excellence Campus for Higher Education and Research (Campus Mare Nostrum), University of Murcia, 30100 Murcia, Spain.
Ernesto Rodríguez-TobónDepartment of Physiology, Veterinary School, International Excellence Campus for Higher Education and Research (Campus Mare Nostrum), University of Murcia, 30100 Murcia, Spain.
Sergio Navarro-SernaDepartment of Physiology, Veterinary School, International Excellence Campus for Higher Education and Research (Campus Mare Nostrum), University of Murcia, 30100 Murcia, Spain.ORCID 0000-0002-5210-1415
Evelyne París-OllerDepartment of Physiology, Veterinary School, International Excellence Campus for Higher Education and Research (Campus Mare Nostrum), University of Murcia, 30100 Murcia, Spain.
Maria OficialdeguiGranja Los Alecos, 31395 Barásoain, Spain.
Xonia Carvajal-VergaraProgram of Regenerative Medicine, Centre for Applied Medical Research (CIMA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), University of Navarra, 31008 Pamplona, Spain.ORCID 0000-0002-6475-3701
Laura OrdovásAragon Agency for Research and Development (ARAID), 50018 Zaragoza, Spain.
Felipe PrósperProgram of Regenerative Medicine, Centre for Applied Medical Research (CIMA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), University of Navarra, 31008 Pamplona, Spain.ORCID 0000-0001-6115-8790
Francisco Alberto García-VázquezDepartment of Physiology, Veterinary School, International Excellence Campus for Higher Education and Research (Campus Mare Nostrum), University of Murcia, 30100 Murcia, Spain.
Xabier L ArangurenProgram of Regenerative Medicine, Centre for Applied Medical Research (CIMA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), University of Navarra, 31008 Pamplona, Spain.ORCID 0000-0002-1834-603X
Navarre Institute of Health Research · ESInstituto Murciano de Investigación Biosanitaria · ESUniversidad de Navarra · ESUniversidad de Zaragoza · ES

Funding

Fundación Séneca 20040/GERM/16Gobierno de Navarra I+D 2020 0011-1365-2020-000287Gobierno de Navarra I+D 2020 0011-1365-2020-000293MINECO UE/RTI2018-094485-B-I00Ministerio de Ciencia e Innovación IJCI-2017-33070Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación SAF2015-64224-RRamón y Cajal State Program MINECO/FSE, RYC-2015-17233RETIC TerCel RD16/0011/0005Spanish Ministry of Science and Innovation PID2019-106380RB-I00/AEI/10.13039/501100011033
6 · The paper itself

Abstract

Each year, tens of thousands of people worldwide die of end-stage organ failure due to the limited availability of organs for use in transplantation. To meet this clinical demand, one of the last frontiers of regenerative medicine is the generation of humanized organs in pigs from pluripotent stem cells (PSCs) via blastocyst complementation. For this, organ-disabled pig models are needed. As endothelial cells (ECs) play a critical role in xenotransplantation rejection in every organ, we aimed to produce hematoendothelial-disabled pig embryos targeting the master transcription factor

Indexed as

CRISPR/Cas9ETV2gene editingporcine embryosvascular development

Identifiers

PMID35883376
PMCPMC9311767
OpenAlexW4285801014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.